926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1819103494069551104 |
|---|---|
| author | Linghua Wang Alexandre Reuben John Heymach Xiang Zhang Ignacio Wistuba Ferdinandos Skoulidis Edwin Parra Minghao Dang Yu Qian Daniel McGrail Ana Galan-Cobo Fuduan Peng Fahao Zhang Saxon Rodriguez |
| author_facet | Linghua Wang Alexandre Reuben John Heymach Xiang Zhang Ignacio Wistuba Ferdinandos Skoulidis Edwin Parra Minghao Dang Yu Qian Daniel McGrail Ana Galan-Cobo Fuduan Peng Fahao Zhang Saxon Rodriguez |
| author_sort | Linghua Wang |
| collection | DOAJ |
| first_indexed | 2024-12-22T01:51:21Z |
| format | Article |
| id | doaj.art-a63d6299d4a241bfab974fd5dd446d9e |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-22T01:51:21Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-a63d6299d4a241bfab974fd5dd446d9e2022-12-21T18:42:54ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.926926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapyLinghua Wang0Alexandre Reuben1John Heymach2Xiang Zhang3Ignacio Wistuba4Ferdinandos Skoulidis5Edwin Parra6Minghao Dang7Yu Qian8Daniel McGrail9Ana Galan-Cobo10Fuduan Peng11Fahao Zhang12Saxon Rodriguez13Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAAff1 grid.240145.60000000122914776Surgical OncologyMD Anderson Cancer Center Houston TX USAThe University of Texas MD Anderson Cancer Center, Houston, TX, USAInstitute of Digestive Disease and The Department of Medicine and Therapeutics,State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences,CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China SARDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAThoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA1MD Anderson Cancer Center, Houston, TX, USA1The University of Texas MD Anderson Cancer Center, Houston, TX, USADiseases & Population (DaP) Geninfo Lab, School of Lifesciences, Westlake University, Hangzhou, Zhejiang, ChinaThe University of Texas MD Anderson Cancer Center, Houston, TX, USAUT MD Anderson Cancer Center, Houston, TX, USAUT MD Anderson Cancer Center, Houston, TX, USAUT MD Anderson Cancer Center, Houston, TX, USAUT MD Anderson Cancer Center, Houston, TX, USA |
| spellingShingle | Linghua Wang Alexandre Reuben John Heymach Xiang Zhang Ignacio Wistuba Ferdinandos Skoulidis Edwin Parra Minghao Dang Yu Qian Daniel McGrail Ana Galan-Cobo Fuduan Peng Fahao Zhang Saxon Rodriguez 926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy Journal for ImmunoTherapy of Cancer |
| title | 926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy |
| title_full | 926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy |
| title_fullStr | 926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy |
| title_full_unstemmed | 926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy |
| title_short | 926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy |
| title_sort | 926 immune profiling of keap1 deficient nsclc development of therapeutic strategies to overcome resistance to immunotherapy |
| work_keys_str_mv | AT linghuawang 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT alexandrereuben 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT johnheymach 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT xiangzhang 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT ignaciowistuba 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT ferdinandosskoulidis 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT edwinparra 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT minghaodang 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT yuqian 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT danielmcgrail 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT anagalancobo 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT fuduanpeng 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT fahaozhang 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy AT saxonrodriguez 926immuneprofilingofkeap1deficientnsclcdevelopmentoftherapeuticstrategiestoovercomeresistancetoimmunotherapy |